Cardiac amyloidosis is an infiltrative cardiomyopathy, resulting from amyloid deposition within the myocardium. In primary systemic (AL-type) 
INTRODUCTION
Restrictive cardiomyopathies are a heterogeneous group of myocardial diseases, whose hallmark echocardiographic finding is severe diastolic dysfunction. They are not common in daily practice, and their initial presentation is diverse. Several clinical, electrocardiographic and echocardiographic features may help in the diagnosis. 
RAPID COMMUNICATIONS

CASE
We present a case of a 43-year-old man, with history of schizophrenia, previously evaluated by different physicians because of swollen tongue and xerostomia, with an inconclusive work-up. He presented to his general practitioner with fatigue, bleeding gums and haematuria in the past two months. His blood test results showed normocytic anaemia, 
VIDEO KEY:
Echocardiogram with parasternal long and short axis and apical four chamber views and 2D speckle tracking longitudinal strain bull's eye. Typical cardiac amyloidosis features are present: left ventricular hypertrophy with granular appearance, dilated atria, thickened atrioventricular valves and interatrial septum, small pericardial effusion and "apical sparing" pattern.
thrombocytopenia and a high spontaneous INR, therefore he was referred to the Internal Medicine clinic. In the first visit, he showed signs and symptoms of overt congestive heart failure and was referred to the emergency department. Chest radiography revealed interstitial oedema and bilateral pleural effusion and the electrocardiogram (ECG) showed sinus tachycardia and low voltage criteria ( Figure 1 ). His hemogram and INR were similar to the previous, and had elevated alkaline phosphatase and gamma glutamyl transferase, high BNP and slight elevation of troponin and creatinine. Echocardiography showed biventricular hypertrophy with preserved ejection fraction, restrictive physiology with elevated filling pressures and relative "apical sparing" on 2D longitudinal strain. He also had thickened interatrial septum and atrioventricular valves and a small pericardial effusion (Figure 2 ; Video). He was admitted to the Cardiology Department for medical treatment, with progressive clinical improvement. Diagnostic work-up showed hypoalbuminemia, low levels of factors V and X, antithrombin III and protein C, elevated b2-microglobulin, ferritin and erythrocyte sedimentation rate, while the serum protein electrophoresis was inconclusive. Alpha-galactosidase levels were borderline low. Abdominal echography was not suggestive of chronic liver disease. Cardiac MRI showed diffuse subendocardial late enhancement. A 24-hour urine collection revealed nephrotic range proteinuria, positive Bence Jones protein and an immunofixation test with a monoclonal lambda protein band. Abdominal fat biopsy was negative for Congo red stain and the genetic study was also negative for mutations in the TTR and GLA genes. Nonetheless, a bone marrow biopsy was performed and it was notable for lambda protein monoclonal plasmocytosis, accounting for 80% of the total cellularity, confirming the diagnosis of primary systemic (AL-type) amyloidosis. He was considered a poor candidate to autologous stem-cell transplantation, due to advanced cardiac involvement, and was started on chemotherapy (CyBORD protocol). Seven cycles were administered, with excellent tolerability and response. The patient is currently on NYHA class II, two years after the initial admission, under regular haematology and cardiology follow-up.
DISCUSSION
This case represents a rare cause of heart failure in a young adult. Cardiac amyloidosis is an infiltrative cardiomyopathy, resulting from amyloid deposition within the myocardium
1,2
. In primary systemic (ALtype) amyloidosis, the amyloid protein is composed of light chains resulting from plasma-cell dyscrasia 2 , and cardiac involvement occurs in up to 50% of the patients , therefore other histologic studies should be performed if the result is negative
2
. Prognosis is dictated by the level of cardiac involvement (<6 months after the onset of heart failure, without treatment), therefore early diagnosis and treatment are crucial 
